PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to halt MS disability in its tracks
Disease control OngoingThis large, late-stage study is testing whether an oral medication called masitinib can slow the worsening of disability in people with progressive forms of multiple sclerosis (MS). Over 96 weeks, 800 participants will take either masitinib or a placebo pill to see which group ex…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
Scientists test re-engineered immune cells to fight untreatable MS
Disease control OngoingThis is an early-phase study testing a new personalized cell therapy called KYV-101 in 10 people with progressive multiple sclerosis (MS) that hasn't improved with standard treatments. Researchers will collect a patient's own immune cells, modify them in a lab to target B cells t…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: Bruce Cree • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Could your own stem cells halt MS? early trial investigates nerve repair
Disease control OngoingThis study is testing whether injecting a patient's own bone marrow stem cells into the spinal fluid can help repair nerve damage and slow the progression of multiple sclerosis (MS). It involves 18 adults with progressive MS, who will receive either the stem cell treatment or a p…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1, PHASE2 • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for halting MS disability: drug trial aims to save crucial arm function
Disease control OngoingThis UK trial is testing whether a drug called cladribine can slow the loss of arm and hand function in people with advanced multiple sclerosis (MS). Over two years, about 200 participants will receive either the drug or a placebo to see which better protects their ability to per…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Can special light reset your body clock and fight MS fatigue?
Symptom relief ENROLLING_BY_INVITATIONThis early-stage study is testing whether a new type of light therapy is safe and tolerable for people with progressive multiple sclerosis (MS). The main goal is to check for any side effects while also gathering initial information on whether the light can help reduce the severe…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC